title: [Clinical observation of clarithromycin treatment for nasosinusitis after nasopharyngeal carcinoma radiotherapy].
abstract: OBJECTIVE
  To observe the clinical treatment effectiveness of clarithromycin for naso-sinusitis after nasopharyngeal carcinoma radiotherapy.
  
  
  METHODS
  Twenty-four cases of naso-sinusitis after one year nasopharyngeal carcinoma radiotherapy were treated with the oral clarithromycin of small dosage (250 mg everyday). The course of treatment were for 12 to 20 weeks. The treatment effectiveness were evaluated with the chronic naso-sinusitis visual analog quality table mark system (VAS) and Lund-Mackay nasal sinuses CT image mark system before and after treatment.
  
  
  RESULTS
  The VAS mark and CT image mark have significant deviation (P < 0.01) among pretherapy, post-treatment and 6 months after drug withdrawal. No significant deviation was found(P > 0.05) between post treatment and 6 months after drug withdrawal. The treatment effectiveness was judged for very good is 9 cases, for the good is 11 cases and for the bad is 4 cases.
  
  
  CONCLUSIONS
  The clarithromycin of small dosage for long-term treatment of naso-sinusitis after nasopharyngeal carcinoma radiotherapy has positive clinical treatment effectiveness, which is a better treatment method.
authors.affiliation: Department of Otorhinolaryngology, Guangzhou University of Chinese Medicine Affiliated Xinhui hospital of Chinese Medicine, Jiangmen, 529100, China.
authors.forename: Zunbin
authors.initials: Z
authors.lastname: Ke
authors.forename: Rongde
authors.initials: R
authors.lastname: Tang
authors.forename: Jianhua
authors.initials: J
authors.lastname: Tan
authors.forename: Zhijian
authors.initials: Z
authors.lastname: Jiang
authors.forename: Zhifang
authors.initials: Z
authors.lastname: Liang
authors.forename: Shaobin
authors.initials: S
authors.lastname: Feng
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy; D011859:Radiography; D012852:Sinusitis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D017291:Clarithromycin